Labcorp Holdings Inc. (LON: 0JSY)

Market Cap	16.46B
Revenue (ttm)	9.49B
Net Income (ttm)	324.93M
Shares Out	n/a
EPS (ttm)	3.83
PE Ratio	50.67
Forward PE	n/a
Dividend	2.25 (0.93%)
Ex-Dividend Date	Feb 27, 2025

Volume	605
Average Volume	231
Open	242.55
Previous Close	241.86
Day's Range	241.78 - 244.25
52-Week Range	195.90 - 244.25
Beta	1.04
RSI	63.98
Earnings Date	Feb 6, 2025

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests tar...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 67,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0JSY

Financial Performance

In 2023, Labcorp Holdings's revenue was $12.16 billion, an increase of 2.51% compared to the previous year's $11.86 billion. Earnings were $418.00 million, a decrease of -67.32%.

Financial numbers in USD